Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure. The ...

For stabilized AMI without left ventricular systolic dysfunction or HF, discontinuing β-blockers after 1 year or longer is noninferior to continuing it.

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...

Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...

CHICAGO, IL — AUGMENT HF, a phase 2 trial of 78 patients with advanced heart failure, showed that an injection of the novel hydrogel Algisyl-LVR hydrogel (LoneStar Heart, Dallas, TX) into their left ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally ...

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Certain heart conditions, including a heart attack, may contribute to an enlarged heart. In these instances, a doctor may recommend left ventricular reconstructive surgery to prevent further ...